Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Sarcoma × Capecitabine × Clear all

Phase

Status

Withdrawn 1 Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Dermatologic 1

Conditions

Breast Neoplasms 59 Colorectal Neoplasms 45 Rectal Neoplasms 35 Pancreatic Neoplasms 27 Stomach Neoplasms 26 Neoplasm Metastasis 24 Neoplasms 19 Colonic Neoplasms 18 Triple Negative Breast Neoplasms 7 Esophageal Neoplasms 6 Liver Neoplasms 5 Brain Neoplasms 5 Adenocarcinoma 5 Carcinoma, Renal Cell 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Hepatocellular 4 Ovarian Neoplasms 3 Head and Neck Neoplasms 3 Colorectal Cancer Metastatic 3 Carcinoma, Ovarian Epithelial 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms, Unknown Primary 2 Melanoma 2 Gastrointestinal Neoplasms 2 Gallbladder Neoplasms 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Squamous Cell 2 Carcinoma 2 Breast Neoplasms, Male 2

Interventions

Doxorubicin 13 Gemcitabine 10 Cyclophosphamide 10 pazopanib 8 Filgrastim 8 Radiotherapy 7 Ifosfamide 7 Cisplatin 7 Irinotecan 6 Docetaxel 6 Radiation 5 Granulocyte Colony-Stimulating Factor 5 Etoposide 5 Trabectedin 4 Magnetic Resonance Spectroscopy 4 Celecoxib 4 Busulfan 4 Albumin-Bound Paclitaxel 4 sargramostim 3 pembrolizumab 3 X-Rays 3 Radiotherapy, Intensity-Modulated 3 Paclitaxel 3 Neoadjuvant Therapy 3 Leucovorin 3 Dexrazoxane 3 Cryosurgery 3 Blotting, Western 3 Bevacizumab 3 130-nm albumin-bound paclitaxel 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03009058 2024-11-25

MODULATE

Immodulon Therapeutics Ltd

Phase 1/2 Terminated

2 enrolled 7 charts

DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡